Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 3
2006 4
2007 7
2008 4
2010 4
2011 4
2012 4
2013 4
2014 8
2015 7
2016 10
2017 15
2018 14
2019 7
2020 5
2021 5
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Update on the Clot Waveform Analysis.
Wada H, Matsumoto T, Ohishi K, Shiraki K, Shimaoka M. Wada H, et al. Among authors: ohishi k. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620912027. doi: 10.1177/1076029620912027. Clin Appl Thromb Hemost. 2020. PMID: 32862666 Free PMC article.
Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.
Edahiro Y, Ohishi K, Gotoh A, Takenaka K, Shibayama H, Shimizu T, Usuki K, Shimoda K, Ito M, VanWart SA, Zagrijtschuk O, Qin A, Kawase H, Miyachi N, Sato T, Komatsu N, Kirito K. Edahiro Y, et al. Among authors: ohishi k. Int J Hematol. 2022 Aug;116(2):215-227. doi: 10.1007/s12185-022-03341-9. Epub 2022 Apr 16. Int J Hematol. 2022. PMID: 35430707 Clinical Trial.
An Evaluation of the Activated Partial Thromboplastin Time Waveform.
Matsumoto T, Wada H, Fujimoto N, Toyoda J, Abe Y MR, Ohishi K, Yamashita Y, Ikejiri M, Hasegawa K, Suzuki K, Imai H, Nakatani K, Katayama N. Matsumoto T, et al. Among authors: ohishi k. Clin Appl Thromb Hemost. 2018 Jul;24(5):764-770. doi: 10.1177/1076029617724230. Epub 2017 Sep 8. Clin Appl Thromb Hemost. 2018. PMID: 28884611 Free PMC article.
Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis.
Oritani K, Ohishi K, Okamoto S, Kirito K, Komatsu N, Tauchi T, Handa H, Saito S, Takenaka K, Shimoda K, Okada H, Amagasaki T, Wakase S, Shimozuma K, Akashi K. Oritani K, et al. Among authors: ohishi k. Curr Med Res Opin. 2018 Mar;34(3):531-537. doi: 10.1080/03007995.2017.1415874. Epub 2018 Jan 4. Curr Med Res Opin. 2018. PMID: 29224367
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells.
Tanaka A, Nishikawa H, Noguchi S, Sugiyama D, Morikawa H, Takeuchi Y, Ha D, Shigeta N, Kitawaki T, Maeda Y, Saito T, Shinohara Y, Kameoka Y, Iwaisako K, Monma F, Ohishi K, Karbach J, Jäger E, Sawada K, Katayama N, Takahashi N, Sakaguchi S. Tanaka A, et al. Among authors: ohishi k. J Exp Med. 2020 Feb 3;217(2):e20191009. doi: 10.1084/jem.20191009. J Exp Med. 2020. PMID: 31704808 Free PMC article.
98 results